Home » Topics » BioWorld MedTech

BioWorld MedTech
RSS

ALKERMES RAISES $35 MILLION IN OFFERING

Oct. 28, 1991

ANALYST LOWERS AMGEN RATING

Oct. 25, 1991

OXFORD, FAIRFIELD PLAN BIOSCIENCE FUND

Oct. 25, 1991

BCG SHOWS PROMISE AGAINST BLADDER CANCER

Oct. 25, 1991

IMCLONE FILES FOR 2 MILLION-SHARE IPO

Oct. 25, 1991

GM-CSF HELPS IMMUNEX TO PROFITABLE QUARTER

Oct. 25, 1991

$1.27M GRANT FOR TAXOL STUDY

Oct. 25, 1991

S.R. ONE EXERCISES RIBI WARRANTS

Oct. 25, 1991

PATENT FLASH !

Oct. 25, 1991

IVAX CANCELS NOVEN ACQUISITION

Oct. 25, 1991

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...